γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus

doi:10.3748/wjg.v29.i28.4416

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 28

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8361)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-1) series.

Item

Count

PDF

190

WORD

HTML

3660

Figures (1-6)

613

Tables (1-1)

577

Sum=5086

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

251

Download

1163

Sum=1414

Publishing Process of This Article

Item

Count

Browse

381

Download

1209

Sum=1590

Jul 28, 2023 (publication date) through Nov 29, 2025

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. Jul 28, 2023; 29(28): 4416-4432
Published online Jul 28, 2023. doi: 10.3748/wjg.v29.i28.4416

Table 1 Univariate analysis of γ-aminobutyric acid B2 receptor expression and clinicopathological characteristics of cholangiocarcinoma patients

Clinicopathological data	GABBR2 expression		P value
Clinicopathological data	High (IHC index ≥ 8)	Low (IHC index < 8)	P value
Diabetic status
DM	13	2	0.109
Non-DM	8	7	0.109
Sex
Male	10	6	0.580
Female	8	3	0.580
Survival
≥ 5 mo	14	6	1.000
< 5 mo	7	3	1.000
Histological type
Papillary	4	6	0.030^a
Non-papillary	17	3	0.030^a
Histological grading
Well differentiated	13	7	0.672
Moderately differentiated	5	1
Poorly differentiated	3	1
Tumor size (longest diameter)
> 7 cm	6	7	0.020^a
≤ 7 cm	15	2	0.020^a
Regional lymph node involvement
Yes	10	8	0.543
No	8	4
Distant metastasis
Metastasis	14	4	0.418
Non-metastasis	7	5	0.418

^aP < 0.05.

GABBR2: γ-aminobutyric acid B2 receptor.

Full Size Table

Citation: Saengboonmee C, Sorin S, Sangkhamanon S, Chomphoo S, Indramanee S, Seubwai W, Thithuan K, Chiu CF, Okada S, Gingras MC, Wongkham S. γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitus. World J Gastroenterol 2023; 29(28): 4416-4432
URL: https://www.wjgnet.com/1007-9327/full/v29/i28/4416.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i28.4416